Home The Word Brain Fast Track My Amedeo FAQ About Flying Publisher   

Fast Track

Ear2MemoryFree App | Free PDF | Web
Learning languages on your smartphone
By BSK

Free Abstracts

  Sexually Transmitted Diseases

  Free Subscription


Articles published in J Virol

Retrieve available abstracts of 29 articles:
HTML format
Text format



Single Articles


    May 2017
  1. DAS D, Smith N, Wang X, Morgan IM, et al
    The Deacetylase SIRT1 Regulates the Replication Properties of Human Papillomavirus 16 E1 and E2.
    J Virol. 2017;91.
    PubMed     Text format     Abstract available


  2. DAY PM, Thompson CD, Lowy DR, Schiller JT, et al
    Interferon Gamma Prevents Infectious Entry of Human Papillomavirus 16 via an L2-Dependent Mechanism.
    J Virol. 2017;91.
    PubMed     Text format     Abstract available


    April 2017
  3. SZALMAS A, Tomaic V, Basukala O, Massimi P, et al
    The PTPN14 Tumor Suppressor Is a Degradation Target of Human Papillomavirus E7.
    J Virol. 2017;91.
    PubMed     Text format     Abstract available


    March 2017
  4. MORI S, Takeuchi T, Ishii Y, Yugawa T, et al
    Human Papillomavirus 16 E6 Upregulates APOBEC3B via the TEAD Transcription Factor.
    J Virol. 2017;91.
    PubMed     Text format     Abstract available


  5. CAMPOS-LEON K, Wijendra K, Siddiqa A, Pentland I, et al
    Association of Human Papillomavirus 16 E2 with Rad50-Interacting Protein 1 Enhances Viral DNA Replication.
    J Virol. 2017;91.
    PubMed     Text format     Abstract available


    January 2017
  6. CULLETON SP, Kanginakudru S, DeSmet M, Gilson T, et al
    Phosphorylation of the Bovine Papillomavirus E2 Protein on Tyrosine Regulates Its Transcription and Replication Functions.
    J Virol. 2017;91.
    PubMed     Text format     Abstract available


  7. HARRIS L, McFarlane-Majeed L, Campos-Leon K, Roberts S, et al
    The Cellular DNA Helicase ChlR1 Regulates Chromatin and Nuclear Matrix Attachment of the Human Papillomavirus 16 E2 Protein and High-Copy-Number Viral Genome Establishment.
    J Virol. 2016;91.
    PubMed     Text format     Abstract available


    October 2016
  8. BRZEZINSKI JD, Felkner R, Modi A, Liu M, et al
    Phosphorylation requirement of murine leukemia virus p12.
    J Virol. 2016 Oct 5. pii: JVI.01178.
    PubMed     Text format     Abstract available


    June 2016
  9. STRICKLAND SW, Vande Pol S
    The Human Papillomavirus 16 E7 Oncoprotein Attenuates AKT Signaling To Promote Internal Ribosome Entry Site-Dependent Translation and Expression of c-MYC.
    J Virol. 2016;90:5611-21.
    PubMed     Text format     Abstract available


  10. JELEN MM, Chen Z, Kocjan BJ, Hosnjak L, et al
    Global Genomic Diversity of Human Papillomavirus 11 Based on 433 Isolates and 78 Complete Genome Sequences.
    J Virol. 2016;90:5503-13.
    PubMed     Text format     Abstract available


    May 2016
  11. KLYMENKO T, Hernandez-Lopez H, MacDonald AI, Bodily JM, et al
    Human Papillomavirus E2 Regulates SRSF3 (SRp20) To Promote Capsid Protein Expression in Infected Differentiated Keratinocytes.
    J Virol. 2016;90:5047-58.
    PubMed     Text format     Abstract available


    March 2016
  12. CHAPPELL WH, Gautam D, Ok ST, Johnson BA, et al
    Homologous Recombination Repair Factors Rad51 and BRCA1 Are Necessary for Productive Replication of Human Papillomavirus 31.
    J Virol. 2015;90:2639-52.
    PubMed     Text format     Abstract available


  13. BERGVALL M, Gagnon D, Titolo S, Lehoux M, et al
    Requirement for the E1 Helicase C-Terminal Domain in Papillomavirus DNA Replication In Vivo.
    J Virol. 2016;90:3198-211.
    PubMed     Text format     Abstract available


    January 2016
  14. HABIGER C, Jager G, Walter M, Iftner T, et al
    Interferon Kappa Inhibits Human Papillomavirus 31 Transcription by Inducing Sp100 Proteins.
    J Virol. 2015;90:694-704.
    PubMed     Text format     Abstract available


    December 2015
  15. GODI A, Facchetti A, Bissett SL, Cocuzza C, et al
    Naturally-Occurring Major and Minor Capsid Protein Variants of HPV45: Differential Recognition by Cross-Neutralizing Antibodies Generated by the HPV Vaccines.
    J Virol. 2015 Dec 30. pii: JVI.02859.
    PubMed     Text format     Abstract available


    November 2015
  16. PACINI L, Savini C, Ghittoni R, Saidj D, et al
    Downregulation of Toll-Like Receptor 9 Expression by Beta Human Papillomavirus 38 and Implications for Cell Cycle Control.
    J Virol. 2015;89:11396-405.
    PubMed     Text format     Abstract available


    October 2015
  17. DIGIUSEPPE S, Keiffer TR, Bienkowska-Haba M, Luszczek W, et al
    Topography of the Human Papillomavirus Minor Capsid Protein L2 during Vesicular Trafficking of Infectious Entry.
    J Virol. 2015;89:10442-52.
    PubMed     Text format     Abstract available


    September 2015
  18. BURREL S, Desire N, Marlet J, Dacheux L, et al
    Genetic diversity within alphaherpesviruses: characterization of a novel variant of herpes simplex virus type 2 (HSV-2).
    J Virol. 2015 Sep 23. pii: JVI.01959.
    PubMed     Text format     Abstract available


  19. VANDEUSEN HR, Kalejta RF
    Deficiencies in cellular processes modulated by the retinoblastoma protein do not account for reduced human cytomegalovirus replication in its absence.
    J Virol. 2015 Sep 16. pii: JVI.01718.
    PubMed     Text format     Abstract available


    August 2015
  20. CHEN AA, Gheit T, Franceschi S, Tommasino M, et al
    Human Papillomavirus Type 18 Genetic Variation and Cervical Cancer Risk Worldwide.
    J Virol. 2015 Aug 12. pii: JVI.01747.
    PubMed     Text format     Abstract available


  21. LO CIGNO I, De Andrea M, Borgogna C, Albertini S, et al
    The Nuclear DNA Sensor IFI16 Acts as a Restriction Factor for Human Papillomavirus Replication through Epigenetic Modifications of the Viral Promoters.
    J Virol. 2015;89:7506-20.
    PubMed     Text format     Abstract available


  22. BISSETT SL, Godi A, Fleury MJ, Touze A, et al
    Naturally Occurring Capsid Protein Variants of Human Papillomavirus Genotype 31 Represent a Single L1 Serotype.
    J Virol. 2015;89:7748-57.
    PubMed     Text format     Abstract available


    July 2015
  23. PIM D, Broniarczyk J, Bergant M, Playford MP, et al
    A NOVEL PDZ DOMAIN INTERACTION MEDIATES THE BINDING BETWEEN HPV-16 L2 AND SORTING NEXIN 27 AND MODULATES VIRION TRAFFICKING.
    J Virol. 2015 Jul 22. pii: JVI.01499.
    PubMed     Text format     Abstract available


  24. BOUKHVALOVA M, McKay J, Mbaye A, Sanford-Crane H, et al
    Efficacy of HSV-2 Glycoprotein D/AS04 vaccine against genital HSV-2 and HSV-1 infection and disease in the cotton rat Sigmodon hispidus model.
    J Virol. 2015 Jul 15. pii: JVI.01387.
    PubMed     Text format     Abstract available


  25. SEAY K, Khajoueinejad N, Zheng JH, Kiser P, et al
    The Vaginal Acquisition and Dissemination of HIV-1 Infection in a Novel Transgenic Mouse Model is Facilitated by Coinfection with HSV-2 and is Inhibited by Microbicide Treatment.
    J Virol. 2015 Jul 8. pii: JVI.01326.
    PubMed     Text format     Abstract available


  26. STRAUB E, Fertey J, Dreer M, Iftner T, et al
    Characterization of the Human Papillomavirus 16 E8 Promoter.
    J Virol. 2015;89:7304-13.
    PubMed     Text format     Abstract available


  27. CERQUEIRA C, Samperio Ventayol P, Vogeley C, Schelhaas M, et al
    Kallikrein-8 Proteolytically Processes Human Papillomaviruses in the Extracellular Space To Facilitate Entry into Host Cells.
    J Virol. 2015;89:7038-52.
    PubMed     Text format     Abstract available


    June 2015
  28. AWASTHI S, Mahairas GG, Shaw CE, Huang ML, et al
    A dual modality HSV-2 vaccine for preventing genital herpes using glycoproteins C and D subunit antigens to induce potent antibody responses and adenovirus vectors containing capsid and tegument proteins as T cell immunogens.
    J Virol. 2015 Jun 3. pii: JVI.01089.
    PubMed     Text format     Abstract available


    May 2015
  29. MCFARLANE M, MacDonald AI, Stevenson A, Graham SV, et al
    Human Papillomavirus 16 Oncoprotein Expression Is Controlled by the Cellular Splicing Factor SRSF2 (SC35).
    J Virol. 2015;89:5276-87.
    PubMed     Text format     Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Sexually Transmitted Diseases is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Design: